SCHEMBL8255658

SCHEMBL8255658

C=C(O)c1cc(C(=O)OC)n2cnc(C(N)=O)c2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
PABPC1 P11940 1/20 0.42
ALDH1A1 P00352 6/20 0.36
KDM4E B2RXH2 4/20 0.36
HPGD P15428 2/20 0.36
HSD17B10 Q99714 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LMNA P02545 1/20 0.32
NPSR1 Q6W5P4 1/20 0.31
DAPK3 O43293 1/20 0.31
JAK2 O60674 1/20 0.31
PRKD3 O94806 1/20 0.31
MAP4K4 O95819 1/20 0.31
ABL1 P00519 1/20 0.31
CSF1R P07333 1/20 0.31
RET P07949 1/20 0.31
MET P08581 1/20 0.31
PDGFRA P16234 1/20 0.31
PRKACA P17612 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8246479 0.91 MEN1 (0.43) MEN1KMT2APABPC1ALDH1A1KDM4E
SCHEMBL8253057 0.90 MEN1 (0.42) MEN1KMT2APABPC1ALDH1A1LMNA
SCHEMBL8247377 0.84 KMT2A (0.44) MEN1KMT2APABPC1ALDH1A1KDM4E
SCHEMBL8256636 0.72 MAPK1 (0.39) KMT2AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL8247376 0.72 TP53 (0.36) MEN1KMT2APABPC1ALDH1A1KDM4E
SCHEMBL8253041 0.71 MEN1 (0.47) MEN1KMT2APABPC1ALDH1A1KDM4E
SCHEMBL8247063 0.70 LCK (0.36) KMT2AALDH1A1KDM4EHPGDHSD17B10
SCHEMBL8255421 0.69 KDM4E (0.42) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL8255673 0.68 MEN1 (0.33) MEN1KMT2APABPC1LMNA
SCHEMBL17730342 0.66 KMT2A (0.50) MEN1KMT2APABPC1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006128184-A2 PYRIMIDINE OR TRIAZINE FUSED BICYCLIC METALLOPROTEASE INHIBITORS ALANTOS-PHARMACEUTICALS, INC. (US) 2006-11-30 WO disclosed